Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
1979 | 1 |
2001 | 1 |
2005 | 2 |
2011 | 1 |
2012 | 1 |
2015 | 1 |
2020 | 1 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study.
Lancet Oncol. 2020 Apr;21(4):519-530. doi: 10.1016/S1470-2045(19)30863-0. Epub 2020 Mar 12.
Lancet Oncol. 2020.
PMID: 32171426
Clinical Trial.
Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer.
Swain SM, Baselga J, Kim SB, Ro J, Semiglazov V, Campone M, Ciruelos E, Ferrero JM, Schneeweiss A, Heeson S, Clark E, Ross G, Benyunes MC, Cortés J; CLEOPATRA Study Group.
Swain SM, et al.
N Engl J Med. 2015 Feb 19;372(8):724-34. doi: 10.1056/NEJMoa1413513.
N Engl J Med. 2015.
PMID: 25693012
Free PMC article.
Clinical Trial.
Item in Clipboard
Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer.
Baselga J, Cortés J, Kim SB, Im SA, Hegg R, Im YH, Roman L, Pedrini JL, Pienkowski T, Knott A, Clark E, Benyunes MC, Ross G, Swain SM; CLEOPATRA Study Group.
Baselga J, et al.
N Engl J Med. 2012 Jan 12;366(2):109-19. doi: 10.1056/NEJMoa1113216. Epub 2011 Dec 7.
N Engl J Med. 2012.
PMID: 22149875
Free PMC article.
Clinical Trial.
Item in Clipboard
Symptomatic metastases to the pituitary infundibulum resulting from primary breast cancer.
Kurkjian C, Armor JF, Kamble R, Ozer H, Kharfan-Dabaja MA.
Kurkjian C, et al. Among authors: armor jf.
Int J Clin Oncol. 2005 Jun;10(3):191-4. doi: 10.1007/s10147-004-0458-5.
Int J Clin Oncol. 2005.
PMID: 15990968
Review.
Item in Clipboard
Catalysis research of relevance to carbon management: progress, challenges, and opportunities.
Arakawa H, Aresta M, Armor JN, Barteau MA, Beckman EJ, Bell AT, Bercaw JE, Creutz C, Dinjus E, Dixon DA, Domen K, DuBois DL, Eckert J, Fujita E, Gibson DH, Goddard WA, Goodman DW, Keller J, Kubas GJ, Kung HH, Lyons JE, Manzer LE, Marks TJ, Morokuma K, Nicholas KM, Periana R, Que L, Rostrup-Nielson J, Sachtler WM, Schmidt LD, Sen A, Somorjai GA, Stair PC, Stults BR, Tumas W.
Arakawa H, et al. Among authors: armor jn.
Chem Rev. 2001 Apr;101(4):953-96. doi: 10.1021/cr000018s.
Chem Rev. 2001.
PMID: 11709862
Item in Clipboard
Remission of natural-killer cell lymphoma of the liver with anti-hepatitis C therapy.
Armor JF, Fazili J, Toubia N, Kern W, Kamble R, Kharfan-Dabaja MA.
Armor JF, et al.
Am J Hematol. 2005 Mar;78(3):212-5. doi: 10.1002/ajh.20286.
Am J Hematol. 2005.
PMID: 15726605
Free article.
Item in Clipboard
Phase-lock control considerations for coherently combined lasers.
Armor JB Jr, Robinson SR.
Armor JB Jr, et al.
Appl Opt. 1979 Sep 15;18(18):3165-75. doi: 10.1364/AO.18.003165.
Appl Opt. 1979.
PMID: 20212824
Item in Clipboard
Cite
Cite